台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    103.0
  • 漲跌
    ▲1.0
  • 漲幅
    +0.98%
  • 成交量
    128
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智基 (6294)籌碼相關-陽信-石牌 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

陽信-石牌 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0700.0022119.05119.50-22119-18.47%
2024/04/1700.008116.50117.00-8111-7.15%
2024/04/1500.0058116.50117.00-58107-53.92%
2024/04/10120128.1300.00127.0012095125.31% 大買/鉅額交易
2024/04/0968123.7900.00124.00687788.12%
2024/03/271121.5000.00122.001661.51%
2024/03/221123.0000.00122.501601.66%
2023/12/0400.000.1113.00113.50-0.121-0.65%
2023/11/011114.0000.00114.001205.00%
2023/06/1900.0025108.50108.00-2555-45.25%
2023/05/121106.0000.00106.501551.80%
2023/04/1100.0030120.55121.00-3040-74.32%
2023/04/1025120.5800.00120.50253964.02%
2023/04/0600.004119.38120.00-437-10.77%
2023/03/2834118.3800.00117.50343497.84%
2023/03/2100.000.2114.00111.00-0.227-0.60%
2022/01/1300.001127.00126.00-123-4.29%
2021/11/091124.5000.00124.501293.36%
2021/04/0100.006139.00139.50-630-19.47%
2021/03/1900.000.9135.00136.00-0.925-3.56%
2021/03/1000.000.1131.00131.00-0.126-0.37%
2021/03/0500.000134.00131.000270.00%
2021/02/2300.001125.50126.00-126-3.79%
2021/02/221125.0000.00125.501263.72%
2020/12/041126.0000.00127.501323.10%
2020/08/2600.003108.67108.50-356-5.27%
2020/08/183107.5000.00107.503555.37%
2020/07/2900.001104.50104.50-163-1.57%
2020/06/2400.001116.00116.00-159-1.67%
2020/06/2300.0010114.50115.00-1057-17.53%
2020/06/2200.006114.50114.50-654-10.95%
2020/06/1900.005114.50114.50-555-9.00%
2020/06/1800.0010114.25115.00-1054-18.43%
2020/06/1700.003113.50113.50-353-5.65%
2020/06/051113.0000.00113.001551.79%
2020/05/223110.3300.00108.503525.67%
2020/05/112107.0000.00106.002444.48%
2020/03/092100.0000.00100.002277.26%
2020/02/2100.007100.00101.50-726-26.77%
2020/01/311100.5000.00100.501253.86%
2020/01/302100.5000.00101.502257.80%
2020/01/177102.0000.00102.5072330.24%
2019/12/271102.0000.00102.001204.96%
2019/12/241102.0000.00102.001195.06%
2019/12/231102.0000.00102.001195.08%
2019/12/202102.0000.00102.502209.96%
2019/12/131102.5000.00102.001204.97%
2019/11/062102.0000.00102.002219.13%
2019/10/252102.0000.00101.502229.05%
2019/10/241102.0000.00102.501224.45%
2019/10/181102.0000.00101.501244.11%
2019/10/162102.0000.00102.002248.13%
2019/10/041101.5000.00102.001273.68%
2019/09/251101.5000.00102.001342.89%
2019/09/241101.5000.00102.001362.72%
2019/09/201101.0000.00101.001372.65%
2019/09/191102.0000.00101.001372.67%
2019/09/182102.000.2101.50102.001.8374.84%
2019/08/051102.0000.00102.001442.23%
2019/08/0200.002102.00102.50-245-4.39%
2019/07/291102.0000.00102.001462.17%
2019/07/231103.5000.00102.501452.19%
2019/07/191102.501102.50103.000440.00%
2019/07/041102.0000.00102.001442.24%
2019/06/212111.0000.00109.502404.91%
2019/06/052110.0000.00109.502424.66%
2019/05/2200.000.6108.50109.50-0.642-1.42%
2019/05/1400.001108.00109.00-143-2.29%
2019/04/250109.0000.00109.500390.08%
2019/04/191108.0000.00107.501382.57%
2019/03/261110.0000.00111.001303.23%
2019/02/1900.004108.50108.50-422-18.06%
2018/11/2000.001104.00103.00-129-3.41%
2018/11/1900.001103.00103.50-129-3.44%
2018/05/141125.001124.50126.0001310.00%
2018/05/0900.004128.50129.00-4127-3.15%
2018/05/0700.001130.00131.50-1124-0.80%
2018/05/0400.002129.00128.50-2117-1.70%
2018/05/031128.5000.00129.0011160.86%
2018/04/0900.001128.00127.00-1164-0.61%
2018/03/2900.001128.50128.50-1161-0.62%
2018/03/211129.5000.00128.5011830.54%
2018/03/2000.001127.00127.50-1178-0.56%
2018/03/161123.0000.00123.5011670.60%
2018/03/1400.001122.00121.50-1171-0.58%
2018/03/1300.001120.50121.00-1171-0.58%
2018/03/091119.0000.00120.0011720.58%
2018/03/0800.003121.00119.50-3171-1.74%
2018/02/2700.001117.50117.00-1172-0.58%
2018/02/091116.0000.00116.0011660.60%
2018/02/082116.2500.00116.0021651.21%
2018/02/071115.0000.00115.0011650.60%
2018/02/021123.001123.00123.0001630.00%
2018/01/3100.002120.25120.00-2163-1.23%
2018/01/0400.000.5112.00112.00-0.598-0.51%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音